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The optimal management of small abdominal aor-
tic aneurysms (AAAs) is controversial. Some recom-
mend early surgery, and others recommend ultra-
sound scan surveillance unless a larger threshold size
is reached or rapid expansion occurs. For this reason,
the recent publication of the results of the United
Kingdom Small Aneurysm Trial (UK Trial) has been
eagerly awaited.1 Initially, some vascular surgeons may
find its results disquieting. No survival rate advantage
could be shown for early surgery in patients with non-
tender 4.0-cm to 5.5-cm diameter AAAs in compari-
son with patients who were followed with serial ultra-
sound scan surveillance until the aneurysm enlarged
to greater than 5.5 cm or was considered to be symp-
tomatic. After the randomization of 1090 patients
aged 60 to 76 years with a mean aneurysm diameter
of 4.6 cm, the 6-year life-table survival rate was
remarkably equivalent at 64% in both groups. This
was caused, in part, by a higher than expected elective
operative mortality rate of 5.8%, which offset a small
reduction in rupture risk and late mortality rates in
the surgical group. As expected, a large number of
patients (61%) who were initially in the surveillance
group underwent AAA repair during the follow-up
period because of AAA expansion or symptoms.
By all standards, this is a well-conducted study for
which the UK Trialists deserve congratulations. As
with any large multi-centered study involving the care
of real patients, some problems are expected. In this
trial, 8% of the patients inappropriately crossed over
into the other treatment group, but an analysis of the
treatment that was actually received did not alter the
conclusions. A more difficult issue is that 20% of the
patients in the surveillance group underwent surgery
because of “tenderness” of the aneurysm. This is a
subjective evaluation that could have introduced a
bias by surgeons who had a concern for individual
patients. However, aneurysm tenderness, especially if
new, is a legitimate indication that could not be avoid-
ed. Finally, it is unfortunate that the cause of death
was determined with autopsy in only 29% of the
deaths because AAA rupture may masquerade as a
cardiac event and be undercounted.
The safety of ultrasound scan surveillance was, in
part, a result of meticulous follow-up: ultrasound
scan studies were performed every 6 months for 4.0-
cm to 4.9-cm AAAs and every 3 months for 5.0-cm
to 5.5-cm AAAs. Compliance with follow-up in the
UK Trial approached 100%, an enviable result that is
not likely to be achieved in routine practice unless a
computerized follow-up program is instituted and
combined with appropriate clinical follow-up to
detect the onset of symptoms or a tender aneurysm.
The UK Trial concluded that ultrasound scan 
surveillance is safe and that open surgical repair for
4.0-cm to 5.5-cm AAAs is not necessary for the aver-
age patient in this study. How should these results
influence our management of a small AAA? Decision
analysis has shown that the proper selection of patients
for AAA repair is primarily influenced by the following
factors: (1) elective operative risk, (2) aneurysm rup-
ture risk, and (3) life expectancy, in combination with
patient preference.2 Thus, rather than reach a global
conclusion concerning the UK Trial, an appropriate
response is to consider the application of each of these
selection factors to the individual patient.
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1. The elective operative mortality rate of 5.8% in
this trial was disappointing and higher than the
2% mortality rate projected in the initial study
design.3 This mortality rate is similar to the
overall results of other multi-centered studies,
such as the Canadian Aneurysm Study (4.7%),4
or other population experiences, such as in
Michigan (5.6%, in 1990).5 However, the mor-
tality rate of elective AAA repair has been
improving over the past decade: 3.8% in the
province of Ontario in 1988 to 1992,6 and 3%
for ages 65 to 69 years and 4% for ages 70 to
74 years in United States Medicare patients in
1995.7 Had the UK Trial achieved an elective
operative mortality rate of 2% to 3%, it is likely
that early surgery would have shown a signifi-
cant benefit. Is it possible to select patients
who will have a low operative risk? Multiple
algorithms have been suggested to predict car-
diac events,8,9 and a large meta-analysis identi-
fied seven prognostic factors that are indepen-
dently predictive of operative mortality rate
after elective AAA repair.10 The absence of the
most important risk factors (renal dysfunction,
congestive heart failure, cardiac ischemia, and
chronic pulmonary disease) can accurately
identify a low-risk group with a predicted oper-
ative mortality rate of 2% or less. The operative
mortality rate associated with elective AAA
repair also is dependent on surgeon and hospi-
tal experience and volume. Thus, to predict the
mortality risk for individual patients, the sur-
geon must consider the patient risk factors and
have knowledge of the operative results.
2. The rupture risk of 4.0-cm to 5.5-cm diameter
AAAs under surveillance in the UK Trial was
low—1% per year. Other investigators previously
have reported the safety of careful surveillance of
small AAAs, with subsequent repair when expan-
sion occurs. With such a strategy in an Ontario
population, Brown et al11 recommended a
threshold diameter of 5.0 cm with computed
tomographic scan for elective AAA repair
because AAA rupture occurred between 5.0 and
5.6 cm during surveillance. Although not statis-
tically significant because of sample size, there
was also a trend in the UK Trial to suggest that
early surgery was relatively more beneficial in the
subgroup of patients with 4.9-cm to 5.5-cm
diameter AAAs. It is important to emphasize that
AAA rupture was avoided in both of these stud-
ies by means of elective repair in approximately
50% of the patients after 3 years. Usually, this
resulted from AAA expansion, which averaged
3.3 mm/y in the UK Trial but was 7.0 mm/y in
the Ontario trial for 4.5-cm to 5.0-cm AAAs.
These results suggest that, for patients with good
life expectancy, the issue of small AAA repair is
only a question of “when”, not “if”. In this sce-
nario, patient preferences should be a guiding
factor. It is unfortunate that rupture risk of indi-
vidual AAAs cannot be determined with more
precision. Although AAA size and documented
expansion are the dominant predictors of rup-
ture, other factors, such as hypertension, chron-
ic pulmonary disease, smoking, family history,
and aneurysm morphology, appear to influence
outcome and can assist individual patient deci-
sion making.12-15
3. Elective AAA repair is a prophylactic operation
intended to prolong life. Thus, it is ideally
applied to patients who have a long life expectan-
cy. Unfortunately, AAAs primarily affect older
patients with other comorbidites that shorten life
expectancy to approximately 60% after 5 years, as
confirmed in the UK Trial. Thus, the optimal
selection of patients for AAA repair necessitates
an accurate assessment of life expectancy in addi-
tion to perioperative risk. On a population basis,
age is the best predictor of life expectancy and
was a significant predictor in the UK Trial. For
an individual patient of a specific age, however,
specific comorbidities are equally important.
After successful AAA repair, long-term survival is
reduced if the patient has coronary artery dis-
ease, renal insufficiency, pulmonary insufficiency,
hypertension, or peripheral atherosclerosis.16
The UK Trial found that reduced long-term sur-
vival was associated with a lower forced expirato-
ry volume at 1 second and a lower ankle brachial
index. Although survival rates are difficult to
predict with precision, by evaluating these risk
factors in combination with age, it is possible to
select a subgroup of patients with small AAAs
who have good long term survival and are more
likely to benefit from surgery.
In a companion article, the UK Trial analyzed
the cost of early surgery versus ultrasound scan sur-
veillance and the associated health-related quality of
life.17 Not surprisingly, the average cost of early
surgery was higher, although the cost of ultrasound
scan surveillance was ultimately increased by the 60%
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of patients who underwent surgery in the surveil-
lance group. Thus, the final cost difference between
the two strategies was reduced to approximately
$2000. Interestingly, the patients who underwent
early surgery reported a positive improvement in
current health perception and a less negative change
in bodily pain than the patients who underwent sur-
veillance. The impact of these results will necessitate
a more formal cost-effectiveness analysis, particular-
ly in the subgroups of patients who might benefit
from early AAA repair. Similarly, the potential
impact of endovascular AAA repair will depend on
the ultimate effectiveness and operative mortality
rate of this technique. If the low operative mortality
rate (2%) reported in the United States multi-cen-
tered trials continues, it is possible that endovascular
repair could have a major impact on the conclusions
of the UK Trial.18,19
Clearly, arbitrarily setting a single threshold
diameter for elective AAA repair in all patients is
naive. In the subgroup of patients who are younger
and healthier or who have additional risk factors for
AAA rupture, elective repair at a smaller size (eg,
4.0 to 5.0 cm) is likely to be beneficial if a low oper-
ative risk can be ensured. To accomplish this, a care-
ful evaluation of operative risk factors is necessary,
which may include a comprehensive analysis of car-
diac risk and treatment when indicated. When sur-
veillance is selected as the optimal strategy, follow-
up must be meticulous to achieve the admirable
results of the UK Trial because half of the patients
will likely require elective repair within 3 years.
Despite the results of the UK Trial, the optimal
timing of elective AAA repair for individual patients
will remain a challenging surgical problem. On the
basis of this study, however, the burden of proof is
clearly shifted onto the surgeon who recommends
early repair, who must assure a low operative mor-
tality rate in these selected patients. Like other pre-
vious studies, the UK Trial has established that care-
ful surveillance with timely elective intervention is
safe for small AAAs. Because the rupture risk is rela-
tively low for these small AAAs, the operative results
must be outstanding to recommend early repair.
Vascular surgeons have long realized that surgical
decision making for patients with small AAAs is
complex and must consider elective operative risk,
aneurysm rupture risk, and life expectancy, in addi-
tion to patient preferences. The UK Trial has pro-
vided additional important data to inform these
decisions.
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